palmidrol has been researched along with Multiple Sclerosis in 6 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Central neuropathic pain is a common debilitating symptom in patients with multiple sclerosis." | 1.38 | Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. ( Hesselink, JM; Kopsky, DJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Petrosino, S | 2 |
| Schiano Moriello, A | 1 |
| Migliore, M | 1 |
| Pontis, S | 1 |
| Fuentes de Arriba, AL | 1 |
| Realini, N | 1 |
| Torrente, E | 1 |
| Armirotti, A | 1 |
| Romeo, E | 1 |
| Di Martino, S | 1 |
| Russo, D | 1 |
| Pizzirani, D | 1 |
| Summa, M | 1 |
| Lanfranco, M | 1 |
| Ottonello, G | 1 |
| Busquet, P | 1 |
| Jung, KM | 1 |
| Garcia-Guzman, M | 1 |
| Heim, R | 1 |
| Scarpelli, R | 1 |
| Piomelli, D | 1 |
| Loría, F | 1 |
| Mestre, L | 1 |
| Spagnolo, A | 1 |
| Correa, F | 1 |
| Hernangómez, M | 1 |
| Guaza, C | 1 |
| Di Marzo, V | 1 |
| Docagne, F | 1 |
| Jean-Gilles, L | 1 |
| Feng, S | 1 |
| Tench, CR | 1 |
| Chapman, V | 1 |
| Kendall, DA | 1 |
| Barrett, DA | 1 |
| Constantinescu, CS | 1 |
| Kopsky, DJ | 1 |
| Hesselink, JM | 1 |
| Baker, D | 1 |
| Pryce, G | 1 |
| Croxford, JL | 1 |
| Brown, P | 1 |
| Pertwee, RG | 1 |
| Makriyannis, A | 1 |
| Khanolkar, A | 1 |
| Layward, L | 1 |
| Fezza, F | 1 |
| Bisogno, T | 1 |
| Di Marzo , V | 1 |
1 review available for palmidrol and Multiple Sclerosis
| Article | Year |
|---|---|
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocan | 2020 |
5 other studies available for palmidrol and Multiple Sclerosis
| Article | Year |
|---|---|
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Disease Models, Animal; Dose-Response Relati | 2016 |
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
Topics: Amides; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cannabinoid Receptor Modulators; Cytoki | 2008 |
Plasma endocannabinoid levels in multiple sclerosis.
Topics: Adult; Aged; Amides; Amidohydrolases; Arachidonic Acids; Brain; Brain Chemistry; Cannabinoid Recepto | 2009 |
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.
Topics: Acupuncture Therapy; Amides; Analgesia; Analgesics; Chronic Disease; Endocannabinoids; Ethanolamines | 2012 |
Endocannabinoids control spasticity in a multiple sclerosis model.
Topics: Amides; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Disease Mo | 2001 |